Grundstein für das "Science Gateway" am CERN gelegt
Am Europäischen Kernforschungszentrum CERN bei Genf ist der Baubeginn für das „Science Gateway“ gefeiert worden Das ehr…
Newsrooms
Immatics Presents Phase I Data from ACTolog® Multi-Target Pilot Study IMA101 at the 35th Annual SITC Conference
Multi-target Adoptive Cell Therapy (ACT) with endogenous T cells against defined pHLA targets demonstrates feasibility…
Immatics Presents Preclinical Proof-of-Concept Data for TCR Bispecifics Program IMA401 Targeting MAGEA4/8
Immatics’ first TCR Bispecific program IMA401 delivers preclinical proof-of-concept demonstrating complete remissions of…
Immatics Appoints Biotech Executive Eliot Forster to Board of Directors
Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and develop…
Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs
First patient has been treated in Germany in Immatics’ ACTengine® IMA202-101 trial German regulatory agency, Paul-Ehrlic…
Immatics Announces Board of Directors Additions Following Public Listing on NASDAQ
Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and develop…
SIXT continues international expansion and acquires strategically important airport branches in the US growth market
SIXT acquires ten strategically important airport branches and is thus represented at nearly every important traffic hub…
Immatics Appoints Cedrik Britten as Chief Medical Officer
Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T c…
Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies
GSK to obtain access to two Immatics TCR-T programs, further advancing their commitment to the field of cell therapies I…
RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada
RadioMedix and gate-Startup OncoBeta today announced the execution of an exclusive distribution agreement for the next g…
